ÂÜÀòÂÒÂ×

Xiaorong Liu currently serves as Director of Medicinal Chemistry at WuXi AppTec, a position held since February 2023. Prior to this role, Xiaorong was Vice President of Chemistry at Berry-Bio, LLC from April 2022 to February 2023, and held the position of Senior Scientist at UCB from May 2018 to April 2022, during which UCB acquired Ra Pharma in April 2020. Previous experience includes serving as Investigator at GlaxoSmithKline from August 2010 to February 2018, Medicinal Chemist at AstraZeneca from January 2010 to August 2010, and Research Team Leader I at Massachusetts General Hospital from November 2006 to January 2010. Xiaorong's academic background includes a Ph.D. in Synthetic Organic Chemistry from the University of Rochester, achieved between 1999 and 2004, and a Postdoctoral Associate position at the University of Illinois at Urbana-Champaign under the mentorship of Prof. Scott E from 2004 to 2006, with initial graduate studies also at the University of Rochester under Prof. Robert K.